Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy-Reference-Cited by-同舟云学术

Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy

Published:2024-03 Issue: Volume:7 Page:100059
ISSN:2772-9761
Container-title:Journal of Molecular and Cellular Cardiology Plus
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology Plus

Author:

Meyer-Jens Moritz,Wenzel Kristin,Grube Karina,Rüdebusch Julia,Krämer Elisabeth,Bahls Martin,Müller Kilian,Voß Hannah,Schlüter Hartmut,Felix Stephan B.,Carrier Lucie,Könemann Stephanie,Schlossarek Saskia^ORCID

Funder

Deutsches Zentrum für Herz-Kreislauf-Forschung eV

Leducq Foundation

Publisher

Elsevier BV

Reference64 articles.

1. Practical guidance on the use of sacubitril/valsartan for heart failure;Sauer;Heart Fail Rev,2019

2. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition;Cruden;Hypertension,2004

3. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure;Rademaker;Clin Sci,1996

4. Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP);Wilkinson;Br J Clin Pharmacol,2001

5. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review;Woods;Clin Exp Pharmacol Physiol,2004

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin-1 influences mechanical properties and contractility of hiPSC derived cardiomyocytes resulting in diastolic dysfunction;Journal of Molecular and Cellular Cardiology;2024-09